Pascal E. R. Girin - May 16, 2025 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Role: Director
Signature: /s/ Danilo D'Alessandro, by Power of Attorney for Pascal E. R. Girin
Stock symbol: CLPT
Transactions as of: May 16, 2025
Transactions value $: $0
Form type: 4
Date filed: 5/19/2025, 05:07 PM
Previous filing: Apr 2, 2025
Next filing: May 23, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Girin Pascal E R	Director	C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH	/s/ Danilo D'Alessandro, by Power of Attorney for Pascal E. R. Girin	2025-05-19	0001329811

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLPT	Common Stock	Options Exercise		+21.1K	+28.12%		96.1K	May 16, 2025	Direct	F1

Showing 1 to 1 of 1 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLPT	Restricted Stock Units	Options Exercise		-21.1K	-100%		0	May 16, 2025	Common Stock	21.1K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

Content

Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.